Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132459) titled 'A Phase I Clinical Study to evaluate the safety, tolerability and pharmacokinetics of Rupatifen Fumarate Capsules in Healthy Subjects' on Sept. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Allergic Rhinitis
Intervention:
Single Dose Trial - Group 5:Rupatifen Fumarate Capsules, 16mg
Single Dose Trial - Group 1:Rupatifen Fumarate Capsules, 1mg
Single Dose Trial - Group 6:Rupatifen Fumarate Capsules, 24mg
Single Dose Trial - Group 4:Rupatifen Fumarate Capsules, 8mg
Single Dose Tri...